Cardiovascular complications of mucocutaneous lymph node syndrome.
The clinical and pathologic changes seen in patients with Kawasaki disease are discussed. Emphasis is placed on the cardiovascular manifestations and the present treatment and suggested long-term follow-up of this disorder.
D000783:Aneurysm / Q000175:diagnosis / Q000209:etiology / Q000503:physiopathology; D001241:Aspirin / Q000627:therapeutic use; D002675:Child, Preschool; D003327:Coronary Disease / Q000175:diagnosis / Q000209:etiology / Q000503:physiopathology; D004452:Echocardiography; D005260:Female; D006331:Heart Diseases / Q000175:diagnosis / Q000209:etiology* / Q000503:physiopathology; D006333:Heart Failure / Q000209:etiology / Q000503:physiopathology; D006349:Heart Valve Diseases / Q000175:diagnosis / Q000209:etiology / Q000503:physiopathology; D006801:Humans; D007223:Infant; D008297:Male; D009080:Mucocutaneous Lymph Node Syndrome / Q000150:complications* / Q000188:drug therapy / Q000473:pathology / Q000503:physiopathology
D001241:Aspirin